UB Paderborn / Katalog / Suche / in CDI

Apoptosis related to telomere instability and cell cycle alterations in human glioma cells treated by new highly selective G-quadruplex ligands

Oncogene, 2005-04, Vol.24 (18), p.2917-2928

2005

Volltextzugriff (PDF)

Stabilization of the c-myc gene promoter quadruplex by specific ligands’ inhibitors of telomerase

Biochemical and biophysical research communications, 2004-10, Vol.323 (3), p.802-808

2004

Volltextzugriff (PDF)

Role of ATM in the telomere response to the G-quadruplex ligand 360A

Nucleic acids research, 2008-03, Vol.36 (5), p.1741

2008

Volltextzugriff (PDF)

SAR and X-ray. A New Approach Combining Fragment-Based Screening and Rational Drug Design: Application to the Discovery of Nanomolar Inhibitors of Src SH2

Journal of medicinal chemistry, 2002-06, Vol.45 (12), p.2379-2387

2002

Volltextzugriff (PDF)

Preferential binding of a G-quadruplex ligand to human chromosome ends

Nucleic acids research, 2005-01, Vol.33 (13), p.4182

2005

Volltextzugriff (PDF)

Targeting human telomerase for cancer therapeutics

Cytotechnology (Dordrecht), 2004-06, Vol.45 (1-2), p.75-90

2004

Volltextzugriff (PDF)

Requirements for specific binding of low affinity inhibitor fragments to the SH2 domain of (pp60)Src are identical to those for high affinity binding of full length inhibitors

Journal of medicinal chemistry, 2003-11, Vol.46 (24), p.5184-5195

2003

Volltextzugriff (PDF)

Imidazole-based ligands of the Src SH2 protein

Bioorganic & medicinal chemistry letters, 2002-05, Vol.12 (9), p.1287-1289

2002

Volltextzugriff (PDF)

Small ligands interacting with the phosphotyrosine binding pocket of the Src SH2 protein

Bioorganic & medicinal chemistry letters, 2002-05, Vol.12 (9), p.1295-1298

2002

Volltextzugriff (PDF)

Small ligands interacting with the phosphotyrosine binding pocket of the Src SH 2 protein

Bioorganic & medicinal chemistry letters, 2002, Vol.12 (9), p.1295-1298

2002

Volltextzugriff (PDF)

Imidazole-based ligands of the Src SH 2 protein

Bioorganic & medicinal chemistry letters, 2002, Vol.12 (9), p.1287-1289

2002

Volltextzugriff (PDF)

Principles Governing the Binding of a Class of Non-Peptidic Inhibitors to the SH2 Domain of src Studied by X-ray Analysis

Journal of medicinal chemistry, 2002-07, Vol.45 (14), p.2915-2922

2002

Volltextzugriff (PDF)

High-affinity Src-SH2 ligands which do not activate Tyr(527)-phosphorylated Src in an experimental in vivo system

Biochemical and biophysical research communications, 2002-10, Vol.298 (2), p.185-192

2002

Volltextzugriff (PDF)

Discovery of highly potent Src SH2 binders: Structure-activity studies and X-ray structures

Bioorganic & medicinal chemistry letters, 2002-05, Vol.12 (9), p.1291-1294

2002

Volltextzugriff (PDF)

Requirements for Specific Binding of Low Affinity Inhibitor Fragments to the SH2 Domain of pp60Src Are Identical to Those for High Affinity Binding of Full Length Inhibitors

Journal of medicinal chemistry, 2003-11, Vol.46 (24), p.5184-5195

2003

Volltextzugriff (PDF)

Requirements for Specific Binding of Low Affinity Inhibitor Fragments to the SH2 Domain of pp60 Src Are Identical to Those for High Affinity Binding of Full Length Inhibitors

Journal of medicinal chemistry, 2003-11, Vol.46 (24), p.5184-5195

2003

Volltextzugriff (PDF)

Discovery of Thioazepinone Ligands for Src SH2: From Non-specific to Specific Binding

Bioorganic & medicinal chemistry letters, 2001-08, Vol.11 (16), p.2127-2131

2001

Volltextzugriff (PDF)

High-affinity Src-SH2 ligands which do not activate Tyr527-phosphorylated Src in an experimental in vivo system

Biochemical and biophysical research communications, 2002-10, Vol.298 (2), p.185-192

2002

Volltextzugriff (PDF)

Discovery of highly potent Src SH 2 binders: Structure–activity studies and X-ray structures

Bioorganic & medicinal chemistry letters, 2002, Vol.12 (9), p.1291-1294

2002

Volltextzugriff (PDF)

High-affinity Src-SH2 ligands which do not activate Tyr 527-phosphorylated Src in an experimental in vivo system

Biochemical and biophysical research communications, 2002, Vol.298 (2), p.185-192

2002

Volltextzugriff (PDF)

Src homology-2 domain binding assays by scintillation proximity and surface plasmon resonance

Journal of molecular recognition, 2001-07, Vol.14 (4), p.254-260

2001

Volltextzugriff (PDF)

Targeting human telomerase for cancer therapeutics: Telomere Biology

Cytotechnology (Dordrecht), 2004, Vol.45 (1-2), p.75-90

2004

Volltextzugriff (PDF)

Toxicity and activity of purified trichosanthin

AIDS (London), 1991-07, Vol.5 (7), p.865-870

1991

Volltextzugriff (PDF)

Protective effects of murine monoclonal antibodies in experimental septicemia: E. coli antibodies protect against different serotypes of E. coli

The Journal of infectious diseases, 1989-04, Vol.159 (4), p.641

1989

Volltextzugriff (PDF)

ChemInform Abstract: Imidazole‐Based Ligands of the Src SH 2 Protein

ChemInform, 2002-09, Vol.33 (35)

2002

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Apoptosis related to telomere instability and cell cycle alterations in human glioma cells treated by new highly selective G-quadruplex ligands

Stabilization of the c-myc gene promoter quadruplex by specific ligands’ inhibitors of telomerase

Role of ATM in the telomere response to the G-quadruplex ligand 360A

SAR and X-ray. A New Approach Combining Fragment-Based Screening and Rational Drug Design: Application to the Discovery of Nanomolar Inhibitors of Src SH2

Preferential binding of a G-quadruplex ligand to human chromosome ends

Targeting human telomerase for cancer therapeutics

Requirements for specific binding of low affinity inhibitor fragments to the SH2 domain of (pp60)Src are identical to those for high affinity binding of full length inhibitors

Imidazole-based ligands of the Src SH2 protein

Small ligands interacting with the phosphotyrosine binding pocket of the Src SH2 protein

Small ligands interacting with the phosphotyrosine binding pocket of the Src SH 2 protein

Imidazole-based ligands of the Src SH 2 protein

Principles Governing the Binding of a Class of Non-Peptidic Inhibitors to the SH2 Domain of src Studied by X-ray Analysis

High-affinity Src-SH2 ligands which do not activate Tyr(527)-phosphorylated Src in an experimental in vivo system

Discovery of highly potent Src SH2 binders: Structure-activity studies and X-ray structures

Requirements for Specific Binding of Low Affinity Inhibitor Fragments to the SH2 Domain of pp60Src Are Identical to Those for High Affinity Binding of Full Length Inhibitors

Requirements for Specific Binding of Low Affinity Inhibitor Fragments to the SH2 Domain of pp60 Src Are Identical to Those for High Affinity Binding of Full Length Inhibitors

Discovery of Thioazepinone Ligands for Src SH2: From Non-specific to Specific Binding

High-affinity Src-SH2 ligands which do not activate Tyr527-phosphorylated Src in an experimental in vivo system

Discovery of highly potent Src SH 2 binders: Structure–activity studies and X-ray structures

High-affinity Src-SH2 ligands which do not activate Tyr 527-phosphorylated Src in an experimental in vivo system

Src homology-2 domain binding assays by scintillation proximity and surface plasmon resonance

Targeting human telomerase for cancer therapeutics: Telomere Biology

Toxicity and activity of purified trichosanthin

Protective effects of murine monoclonal antibodies in experimental septicemia: E. coli antibodies protect against different serotypes of E. coli

ChemInform Abstract: Imidazole‐Based Ligands of the Src SH 2 Protein

Suchergebnisse filtern